Pharma Focus Asia
Klöckner Pentaplast - Pentapharm® alfoil® films

Evogene Developed Breakthrough ChemPass AI Tech-Engine for Target-Protein Discovery

Evogene has recently unveiled the revolutionary ChemPass AI Tech-Engine, featuring cutting-edge machine learning technology tailored for target-protein discovery.

The ChemPass AI Tech-Engine and the TargetSelector application would signify a significant advancement in the field of target-protein discovery and small molecule identification. 

By utilising machine learning and predictive biology, ChemPass AI appears to be a powerful platform that can efficiently analyse vast amounts of data to identify suitable target-proteins for new products.

The integration of TargetSelector further enhances this platform by streamlining the discovery process, reducing development time, and allocating resources more effectively. 

This combination of AI-driven technology has the potential to increase the likelihood of success in identifying optimal target-proteins and active molecules for various applications, revolutionising the discovery processes.

ChemPass AI boasts remarkable capabilities in swiftly evaluating an organism's proteome and analysing billions of potential candidates with exceptional speed and precision. As a result, the process of identifying promising target-proteins and lead molecules is significantly expedited, leading to a considerable reduction in the time required for discovery.

magazine-slider-imageBIOVIA from Molecule to MedicineMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024Advance DoE WorkshopCPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinRehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024